Kontigo Care Q1: Stable growth trajectory - Redeye

Redeye maintains the valuation of Kontigo Care at SEK 12 per share. The company beats our revenue expectations and continues to grow both in the public and private payor markets as well as internationally. We argue that it is a solid long-term investment case.

Länk till analysen i sin helhet: https://www.redeye.se/research/843023/kontigo-care-q1-stable-growth-trajectory?utm_source=finwire&utm_medium=RSS